<DOC>
	<DOC>NCT01010152</DOC>
	<brief_summary>The objective of this study was to assess the comparative bioavailability of codeine from Roxane Laboratories' Codeine Sulfate 30mg tablets to TylenolÂ® #3 (acetaminophen 300mg with codeine phosphate 30mg) under fasted conditions</brief_summary>
	<brief_title>Comparative Bioavailability Study of Codeine Sulfate</brief_title>
	<detailed_description />
	<mesh_term>Codeine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening. Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to codeine sulfate or any comparable or similar product.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>